Found 2 results
Filters: Author is J.L. Hu  [Clear All Filters]
Y. Hu, Zhang, W. L., Xie, S. L., Zhao, Y., Hu, J. L., Cai, X. F., Lai, G. Q., and Huang, A. L., An improved reverse dot hybridization for simple and rapid detection of adefovir dipivoxil-resistant hepatitis B virus, vol. 11, pp. 53-60, 2012.
Aloman C and Wands JR (2003). Resistance of HBV to adefovir dipivoxil: a case for combination antiviral therapy? Hepatology 38: 1584-1587. PMid:14655682 Chan V, Yam I, Chen FE and Chan TK (1999). A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br. J. Haematol. 104: 513-515. PMid:10086788 Dai CY, Chuang WL, Hsieh MY and Lee LP (2007). Adefovir dipivoxil treatment of lamivudine-resistant chronic hepatitis B. Antiviral Res. 75: 146-151. PMid:17400303 Delaney WE (2007). Progress in the treatment of chronic hepatitis B: long-term experience with adefovir dipivoxil. J. Antimicrob. Chemother. 59: 827-832. PMid:17332007 Fung SK, Chae HB, Fontana RJ, Conjeevaram H, et al. (2006). Virologic response and resistance to adefovir in patients with chronic hepatitis B. J. Hepatol. 44: 283-290. PMid:16338024 Hadziyannis SJ, Tassopoulos NC, Heathcote EJ, Chang TT, et al. (2006). Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years. Gastroenterology 131: 1743-1751. PMid:17087951 Lok AS, Zoulim F, Locarnini S, Bartholomeusz A, et al. (2007). Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management. Hepatology 46: 254-265. PMid:17596850 Lovicu M, Dessi V, Zappu A, De VS, et al. (2003). Efficient strategy for molecular diagnosis of Wilson disease in the sardinian population. Clin. Chem. 49: 496-498. PMid:12600964 Luan J, Yuan J, Li X, Jin S, et al. (2009). Multiplex detection of 60 hepatitis B virus variants by maldi-tof mass spectrometry. Clin. Chem. 55: 1503-1509. PMid:19541863 Moskovitz DN, Osiowy C, Giles E, Tomlinson G, et al. (2005). Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B, role of genotype and drug resistance. J. Viral. Hepat. 12: 398-404. PMid:15985011 Ohishi W, Shirakawa H, Kawakami Y, Kimura S, et al. (2004). Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping. J. Med. Virol. 72: 558-565. PMid:14981758 Osiowy C, Villeneuve JP, Heathcote EJ, Giles E, et al. (2006). Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J. Clin. Microbiol. 44: 1994-1997. PMid:16757589    PMCid:1489409 Perz JF, Armstrong GL, Farrington LA, Hutin YJ, et al. (2006). The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J. Hepatol. 45: 529-538. PMid:16879891 Santantonio T, Fasano M, Durantel S, Barraud L, et al. (2009). Adefovir dipivoxil resistance patterns in patients with lamivudine-resistant chronic hepatitis B. Antivir. Ther. 14: 557-565. PMid:19578241 Tran N, Berne R, Chann R, Gauthier M, et al. (2006). European multicenter evaluation of high-density DNA probe arrays for detection of hepatitis B virus resistance mutations and identification of genotypes. J. Clin. Microbiol. 44: 2792-2800. PMid:16891494    PMCid:1594645 Villet S, Pichoud C, Billioud G, Barraud L, et al. (2008). Impact of hepatitis B virus rtA181V/T mutants on hepatitis B treatment failure. J. Hepatol. 48: 747-755. PMid:18331765 Wang YZ, Xiao JH, Ruan LH, Zhang HY, et al. (2009). Detection of the rtA181V/T and rtN236T mutations associated with resistance to adefovir dipivoxil using a ligase detection reaction assay. Clin. Chim. Acta 408: 70-74. PMid:19651117 Zhao Y, Zhang XY, Guo JJ, Zeng AZ, et al. (2010). Simultaneous genotyping and quantification of hepatitis B virus for genotypes B and C by real-time PCR assay. J. Clin. Microbiol. 48: 3690-3697. PMid:20720032    PMCid:2953110